Study S001243

Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04535960
Acronym: NATRIURETIC
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: NONE
Status: UNKNOWN
Enrollment: 36
Start: 2019-01-24
Primary completion: 2023-10
Lead sponsor: University Health Network, Toronto
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG:Empagliflozin 25 MG + Liraglutide 1.8 MG; DRUG:Liraglutide 1.8 MG + Empagliflozin 25 MG
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Proximal tubular natriuresis [up to 12 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.